Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study

Annals of Neurology

Volumn 52, Issue 2, 2002, Pages 168-174

  Schmidt, Reinhold ^a   Schmidt, Helena ^a   Curb, J David ^b   Masaki, Kamal ^b   White, Lon R ^b   Launer, Lenore J ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; AGING; ARTICLE; ASIA; BRAIN RADIOGRAPHY; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNITED STATES;

ALZHEIMER DISEASE; C-REACTIVE PROTEIN; COHORT STUDIES; DEMENTIA; DEMENTIA, VASCULAR; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS;

EID: 0036321773     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10265     Document Type: Article

References (50)

1. High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
2. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial
3. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project
4. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
5. Infections, inflammation, and the risk of coronary heart disease
6. Serum C-reactive protein and self-reported stroke. Findings from the Third National Health and Nutrition Examination Survey
7. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons
8. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
9. Association of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
10. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
11. C-reactive protein: Relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men
12. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon?
13. Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method
14. The importance of inflammatory mechanisms in Alzheimer disease
15. Inflammation and Alzheimer disease: The good, the bad, and the ugly
16. Blood levels of histamine, IL-1 beta and TNF-alpha in patients with mild to moderate Alzheimer disease
17. Acute phase reactant alpha i-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease
18. Circulating cytokines in Alzheimer's disease
19. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections
20. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease
21. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Introduction
22. Prevalence of dementia in older Japanese-American men in Hawaii: The Honululu-Asia Aging Study
23. ApoE-ε4 predicts incident AD in Japanese-American men: The Honolulu-Asia Aging Study
24. The cognitive abilities screening instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia
25. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia
26. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part I. Clinical and neuropsychological assessment of Alzheimer's disease
27. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
28. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
29. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population based study
30. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
31. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses
32. Midlife blood pressure and dementia: The Honululu-Asia aging study
33. Vascular risk factors in dementia
34. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
35. Atherosclerosis, apolipoprotein E, and presence of dementia and Alzheimer's disease in the Rotterdam Study
36. Risk of dementia among persons with diabetes mellitus: A population-based cohort study
37. Trends in stroke incidence and mortality in Hawaiian Japanese men
38. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
39. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurement in healthy adults
40. Long-term effects of pravastatin on plasma concentration of C-reactive protein
41. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice
42. An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis
43. Cerebral microvascular pathology in aging and Alzheimer's disease
44. Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer's disease
45. Systemic complement activation in ischemic stroke
46. Frequency of stages of Alzheimer-related lesions in different age categories
47. Levels of interleukin-6, CRP and alpha 2 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damage
48. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty